Breaking News

Touchlight, University of Nottingham Partner to Develop Zika DNA Vaccine

Touchlight to supply dbDNA to the research and development team at the university.

Author Image

By: Charlie Sternberg

Associate Editor

Touchlight, a leading contract development and manufacturing organization (CDMO) specializing in enzymatic DNA production, is partnering with the University of Nottingham to advance the development of a next-generation DNA vaccine targeting the Zika virus.   The University of Nottingham research team, led by Dr. James Dixon and Professor Janet Daly, is working to create a DNA vaccine that can be rapidly manufactured and distributed globally to combat future Zika outbreaks. The team’s inn...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters